The most advanced malaria sub-unit vaccine, RTS,S/AS01, is based on the circumsporozoite protein (CSP), and reduces the incidence of clinical malaria by about 30% in young children [3] but has not been shown to prevent parasitemia in adults in endemic areas [4]. The gene discussed is DNAJC5; the disease is malaria.